The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...

Initiated IND-enabling toxicology program IND submission planned for 4Q25; Clinical data expected in 1H26 CRANBURY, N.J., March 25, 2025 /PRNewswire/ -- Palatin ...

Drug developers can now leverage large language models to draft regulatory documents, which they hope will shorten the time ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

The AD/PD™ 2025 conference brings together the brightest minds in the field in order to share the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical ...

The "Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route ...

For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more ...

Five defendants have been sentenced to a total of 70 years in federal prison for their roles in a large methamphetamine, cocaine, and fentanyl trafficking conspiracy. The sentences ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...